$MYCOF News
Last published 4y ago
- 4y agoMYCOFMydecine Announces MYCO-005 Family of Improved Safety Microdose Novel MoleculesGlobeNewswireDENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today annou
- 4y agoMYCOFMydecine's Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in CanadaGlobeNewswireVANCOUVER, British Columbia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction d
- 4y agoMYCOFMydecine Welcomes Dr. Victoria Hale as Newest Independent Board MemberGlobeNewswireVANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disord
- 4y agoMYCOFMydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical TrialGlobeNewswireDENVER, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction diso
- 4y agoMYCOFMydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in VeteransGlobeNewswireDENVER, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction diso
- 4y agoMYCOFMydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health Canada's Special Access ProgramGlobeNewswireVANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental heal
- 4y agoMYCOFMydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For PatientsGlobeNewswireVANCOUVER, British Columbia, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental heal
- 4y agoMYCOFIBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Josh Bartch, CEO of Mydecine Innovations Group Inc.GlobeNewswireNEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the lates
- 4y agoMYCOFMydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of CompoundsGlobeNewswireThe new serotonin receptor model (5-HT2A) will allow the Company to rapidly increase drug analysis promoting near-term patent filings for novel psychedelic molecules. DENVER, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO)
- 4y agoMYCOFMydecine Innovations Group Engages JBN Partners, LLC for Marketing ServicesGlobeNewswireVANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a biotechnology and digital technology company aiming to transform the treatment of mental heal
- 4y agoMYCOFIBN (InvestorBrandNetwork) Announces Gamechangers LIVE Interview with Mydecine Innovations Group Inc. CEO Joshua BartchGlobeNewswireNEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted financial news and publishing company for private and public entities, today announces that Joshua Bartch, Co-Founder, Chairman and CEO of Mydec
- 4y agoMYCOFMydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted TreatmentsGlobeNewswireDENVER, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NF.F) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction dis
- 4y agoMYCOFMydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology InitiativesGlobeNewswireDENVER, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction diso
- 4y agoMYCOFMydecine Files Full Patent Application Covering Multiple Families of Psilocin AnalogsGlobeNewswireDr. Saeid Babaei Appointed Independent Board Member as Mydecine Moves Closer to NASDAQ Listing in Q1 2022 DENVER, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biote
- 4y agoMYCOFMydecine Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewswire--To Launch Phase 2/3 Smoking Cessation Clinical Trial with Johns Hopkins University (JHU) Signed 5-Year Research Agreement with JHU to Further Mydecine's Research of Multiple Molecules for a Variety of Indications -- DENVER, Nov. 16, 2021 (GLOBE
- 5y agoMYCOFMydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leader in Emerging Psychedelic-Assisted Psychotherapy IndustryGlobeNewswireNEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) announces the availability of a broadcast titled, "Breaking the Habit: Psychedelic Stigma Fades as Research Points to Crit
- 5y agoMNMDMYCOFPSILSEELPsychedelics Offer Hope for Mental Disorders, AddictionPR NewswireNEW YORK, Nov. 3, 2021 /PRNewswire/ -- Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in medicine to address some of the most resistant, de
- 5y agoMYCOFMydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion Technology to Traditional Medicine IngredientsGlobeNewswireDENVER, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction diso
- 5y agoMYCOFMydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research RenaissanceGlobeNewswireNEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands in the Investo
- 5y agoATAICMPSCYBNFTRP+1Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and MorePR NewswireNEW YORK, Nov. 1, 2021 /PRNewswire/ -- There isn't a cigarette smoker in the world who doesn't know smoking is bad for them. The problems are that nicotine is one of the most highly addictive substances in the world, and for the nearly 70% of 34.1 millio
- 5y agoMYCOFMydecine to Participate in Wonderland: Miami on November 8-9, 2021GlobeNewswireDENVER, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a biotechnology and digital technology company focused on the treatment of mental health disorders and addiction, to
- 5y agoMYCOFMydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of PsilocinGlobeNewswireFurther strengthens the Company's drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use DENVER, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations
- 5y agoAWKNFBETRFBMBIFCYBN+16KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand ViewingPR NewswireNEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
- 5y agoAWKNFBETRFBMBIFCYBN+13KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14thPR NewswireNEW YORK, Oct. 11, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference. Individual investors, institutional inves
- 5y agoMYCOFMydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew JohnsonGlobeNewswireDENVER, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a biopharmaceutical company focused on the treatment of mental health disorders and addiction, today announced that
- 5y agoMYCOFMydecine Completes Spin-Out of U.S. Cannabis AssetsGlobeNewswireDENVER, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biopharmaceutical company focused on the treatment of mental health and addiction, today announced that it has com
- 5y agoFTRPFMYCOFSEELTRYPFPsychedelics Called the 'Next Frontier' for Investors, Also Offer Promising TreatmentsPR NewswireNEW YORK, Sept. 29, 2021 /PRNewswire/ -- The fact that psychedelics is a nascent industry doesn't seem to be discouraging savvy investors exploring the opportunities. A recent Fortune article noted that "despite being an industry in its early stages, the
- 5y agoMYCOFMydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical DataGlobeNewswireDENVER, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), a biopharmaceutical company focused on the treatment of mental health and addiction, today announced that it has file
- 5y agoCMPSLKYSFMNMDMYCOFNational Suicide Prevention Week Shines Light on Psychedelic TreatmentsPR NewswireNEW YORK, Sept. 9, 2021 /PRNewswire/ -- National Suicide Prevention Week is here and it's not only an opportunity to talk about mental health, but to also look at potential treatments. Suicide remains a leading cause of death in the US and mainstream med
- 5y agoMYCOFMydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical TrialGlobeNewswireDr. Matthew Johnson will lead research to look at the science and efficacy of MYCO-001 for the treatment of smoking cessation and nicotine dependence DENVER, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FS
- 5y agoMYCOFMydecine to Participate in Upcoming Conferences in September 2021GlobeNewswireDENVER, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and addicti
- 5y agoMYCOFMydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis AssetsGlobeNewswireDENVER, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:MYCOF) ("Mydecine" or the "Company"), is pleased to announce that it has filed and mailed its management information circular (the "Information Circular") and re
- 5y agoMYCOFMydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of MedicineGlobeNewswireDENVER, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) announces it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, with research to be led by Professor of Psychiat
- 5y agoMYCOFMydecine Reports Second Quarter 2021 Financial Results and Provides Business UpdateGlobeNewswireGroundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0, its Digital Health Platform to Support the Adoption of Psychedelics into Mental Health and Inner Wellness DENVER, Aug. 16, 2021
- 5y agoMYCOFMydecine to Participate in Upcoming Investor Events in August 2021GlobeNewswireDENVER, July 28, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoLKYSFMNMDMYCOFSEEL+1Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental IllnessPR NewswireNEW YORK, July 21, 2021 /PRNewswire/ -- The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psilocybin and psychedelics in the treatment of ch
- 5y agoMYCOFMydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like CompoundsGlobeNewswireDENVER, July 21, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoDOCRFHIMSMYCOFT+2Telehealth Boom Is Driving this Mental Health Company's ProgressPR NewswireNEW YORK, July 13, 2021 /PRNewswire/ -- Telehealth services boomed during 2020, as patients stuck at home required safe access to vital services, and are expected to continue post-pandemic. Before the public health emergence, only 14,000 Medicare benefic
- 5y agoMYCOFRoth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021GlobeNewswireNEWPORT BEACH, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Roth Capital Partners ("Roth"), www.roth.com, is set to virtually present the Roth Virtual Healthcare Private Company Forum on June 28th, 2021. This event will consist
- 5y agoAURQFBETRFBYRNEDXC+16Proactive news headlines including Planet 13 Holdings, Numinus Wellness, Plurilock Security, Albert Labs and Byrna TechnologiesGlobeNewswireNew York , June 24, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Esports Entertainment Group Inc (NASDAQ:GMBL) partne
- 5y agoMYCOFMydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004GlobeNewswireDENVER, June 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoMYCOFMydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28thGlobeNewswireDENVER, June 23, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoACSTAUSAFBIOCBKLLF+13Proactive news headlines including Royal Road Minerals, Great Panther Mining, PharmaDrug, Codebase Ventures and Nextech AR SolutionsGlobeNewswireNew York , June 22, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Roth says Mydecine Innovations Group Inc (NEO:MYCO
- 5y agoMYCOFMydecine Unveils Artificial Intelligence Drug Discovery ProgramGlobeNewswireDENVER, June 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoMYCOFMydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in MushroomsGlobeNewswireDENVER, June 08, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoMYCOFMydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17thGlobeNewswireDENVER, June 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternativ
- 5y agoABMLAUIAFBLONFCBDHF+18Proactive news headlines including GoviEx Uranium, Snowline Gold, Electric Royalties and Namaste TechnologiesGlobeNewswireNew York, May 25, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Esports Entertainment Group Inc (NASDAQ:GMBL) inks de
- 5y agoMYCOFHealth Canada Approves Expansion of Mydecine's Cultivation Capabilities for Psilocybin Producing MushroomsGlobeNewswireDENVER, May 25, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative
- 5y agoBNVIFCBGZFCCWOFDSMTF+12Proactive news headlines including PlantX Life, Mydecine Innovations, Atlas Engineered Products and Deep-South ResourcesGlobeNewswireNew York , May 19, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: VR Resources Ltd (CVE:VRR) (OTCQB:VRRCF) (FRA:5VR) ex
- 5y agoMYCOFMydecine Provides Update on Spin-Out of U.S. Cannabis AssetsGlobeNewswireDENVER, May 19, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of altern